A Prospective Randomized Sdudy Comparing MVP and MVP Regimens in the Treatment of Advanced Non-small Cell Lung Cancer

Objective To evaluate the recent and long response and toxicity of MVP and HVP regimens in the treatment of advanced NSCLC. Methods A total of 88 cases with advanced NSCLC was randomized into two groups: MVP group (MMC+VDS+DDP), HVP group (HCPT+VDS+DDP). All patients received 3～5 cycles of chemotherapy except 4 patients. Results The response rate was 36%(15/42) in the MVP and 26%(11/42) in the HVP, no significant difference was detected between the groups (P>0.05). No significant difference was detec...